$199 Million is the total value of GOLDMAN CAPITAL MANAGEMENT INC's 33 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 13.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWSY | Buy | Imageware Systems Inc. | $74,013,000 | -4.8% | 34,747,610 | +0.5% | 37.11% | -3.9% |
MDCA | Buy | Mdc Partners Inc New Cl A Subo | $9,477,000 | -7.1% | 493,850 | +4.0% | 4.75% | -6.1% |
REFR | Buy | Research Frontiers Inc | $9,287,000 | +1.2% | 1,615,089 | +6.6% | 4.66% | +2.2% |
MATR | Buy | Mattersight Corp | $7,577,000 | +16.8% | 1,400,400 | +14.7% | 3.80% | +18.0% |
TRIB | Buy | Trinity Biotech | $5,651,000 | -19.5% | 309,297 | +1.5% | 2.83% | -18.7% |
CYRN | Buy | Cyren Ltd | $2,992,000 | +43.3% | 1,366,000 | +88.4% | 1.50% | +44.8% |
CXDO | Buy | Crexendo Inc. | $2,228,000 | -6.9% | 755,193 | +1.0% | 1.12% | -5.9% |
DPDW | Buy | Deep Down Inc | $1,879,000 | -24.8% | 1,361,000 | +0.7% | 0.94% | -24.0% |
OPRX | Buy | OptimizeRX Corp | $1,836,000 | +5.6% | 1,529,334 | +39.9% | 0.92% | +6.7% |
CYTX | Buy | Cytori Therapeutics Inc | $1,095,000 | -54.3% | 1,609,576 | +57.4% | 0.55% | -53.8% |
QTM | Buy | Quantum Corp | $696,000 | +14.1% | 600,000 | +20.0% | 0.35% | +15.2% |
SLTC | Buy | Selectica Inc | $660,000 | +207.0% | 110,080 | +230.2% | 0.33% | +209.3% |
WAVX | Buy | Wave Systems Corp | $549,000 | -13.7% | 512,282 | +13.6% | 0.28% | -13.0% |
AAOI | New | Applied Optoelectronics Inc. | $500,000 | – | 31,000 | +100.0% | 0.25% | – |
LIQT | New | LiqTech Intl Inc. | $456,000 | – | 295,849 | +100.0% | 0.23% | – |
MLSS | Buy | Milestone Scientific Inc | $396,000 | +4.2% | 213,550 | +6.8% | 0.20% | +5.3% |
Buy | Pivotal Therapeutics Inc. | $103,000 | +27.2% | 1,026,889 | +2.7% | 0.05% | +30.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Imageware Systems Inc. (IWSY) | 19 | Q4 2017 | 54.4% |
Icg Group Inc | 19 | Q4 2017 | 11.0% |
Park City Group Inc. (PCYG) | 19 | Q4 2017 | 7.3% |
MDC Partners Inc New Cl A Subo (MDCA) | 19 | Q4 2017 | 7.7% |
Mattersight Corp (MATR) | 19 | Q4 2017 | 7.9% |
Research Frontiers Inc (REFR) | 19 | Q4 2017 | 7.1% |
Trinity Biotech (TRIB) | 19 | Q4 2017 | 4.5% |
Charles & Colvard Ltd (CTHR) | 19 | Q4 2017 | 11.2% |
Deep Down Inc (DPDW) | 19 | Q4 2017 | 1.4% |
Crexendo Inc.(CXDO) | 18 | Q3 2017 | 1.2% |
View GOLDMAN CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CYREN Ltd. | February 22, 2016 | 2,092,131 | 5.3% |
Crexendo, Inc. | February 17, 2015 | 753,054 | 6.7% |
DOT HILL SYSTEMS CORP | February 17, 2015 | 4,093,317 | 6.8% |
PHOTOMEDEX INC | January 07, 2015 | 1,050,099 | 5.5% |
OptimizeRx Corp | October 24, 2014 | 1,532,394 | 6.5% |
CHARLES & COLVARD LTD | April 03, 2014 | 1,344,494 | 6.7% |
Bacterin International Holdings, Inc. | December 12, 2013 | 1,500,000 | 2.9% |
LOCAL Corp | September 26, 2013 | 123 | 0.0% |
RESEARCH FRONTIERS INC | September 26, 2013 | 1,179,000 | 5.1% |
TRINITY BIOTECH PLC | January 28, 2013 | 622,000 | 2.9% |
View GOLDMAN CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-02-14 |
13F-HR | 2017-11-09 |
13F-HR | 2017-08-14 |
13F-HR | 2017-05-09 |
13F-HR | 2017-01-19 |
13F-HR | 2016-10-31 |
13F-HR | 2016-07-29 |
13F-HR | 2016-05-13 |
SC 13G | 2016-02-22 |
13F-HR | 2016-02-16 |
View GOLDMAN CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.